India, May 12 -- A study published in the medical journal Science Progress examined the link between GLP-1 medications and hair loss among patients undergoing rapid weight loss, NewsNation reports.
According to the research, semaglutide and tirzepatide, sold under brand names including Ozempic, Wegovy, Mounjaro and Zepbound, were associated with the highest reported rates of hair loss.
"Although infrequently classified overall, androgenetic alopecia and telogen effluvium were the predominant subtypes of hair loss reported," the study stated.
Dr. Paradi Mirmirani, a contributor to the study, said the side effect was most commonly seen in patients taking higher doses of GLP-1 medications for obesity treatment or rapid weight loss. Meanwhil...